Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02464176 · ClinicalTrials.gov registry record · Phase 4
Systemic Steroids for Peripheral Nerve Blocks
A Phase 4 study, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- Phase 4
- Development phase
- 115
- Enrollment target
NCT02464176 is a Phase 4 study that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 115 participants.
The verdict
NCT02464176, a Phase 4 study, has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 115 participants
- Enrollment target
Study Summary
This study will investigate the ability of systemic dexamethasone to prolong the sensory block duration for lumbar plexus nerve blockade.
Interventions
- DRUG Bupivacaine
- DRUG Dexamethasone
- DRUG Epinephrine
- DRUG Saline
- PROCEDURE Lumbar Plexus Nerve Block
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-01 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02464176
The ClinicalTrials.gov registry entry for NCT02464176 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Bupivacaine is the first listed.
NCT02464176 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02464176 about?
NCT02464176 is a clinical study titled "Systemic Steroids for Peripheral Nerve Blocks". This study will investigate the ability of systemic dexamethasone to prolong the sensory block duration for lumbar plexus nerve blockade.
What is the current status of trial NCT02464176?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 115 participants. The study started on 2015-06. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02464176?
The interventions under investigation include: Bupivacaine (DRUG), Dexamethasone (DRUG), Epinephrine (DRUG), Saline (DRUG), Lumbar Plexus Nerve Block (PROCEDURE).
Who is sponsoring clinical trial NCT02464176?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.